Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.
BioNTech and Pfizer have announced that a vaccine for the coronavirus that they have developed was more than 90% effective in preventing the disease among trial volunteers who had no evidence of having previously been infected.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2025. All rights reserved.